The Mucosal and Vaccine Research Colorado (MAVRC) program promotes disease prevention by fostering collaborative and innovative research to understand human immunology, mucosal and vaccine biology.
Mucosal tissues are the moist surfaces of the body that provide the first line of host defense. These surfaces most often successfully exclude harmful elements from the body. However, the most common infections (pneumonia, ear and urinary tract infections, gingivitis, diarrhea and HIV/AIDS) and cancers (lung, colon, breast, and prostate) begin at the mucosa.
Creative solutions to prevent infections, cancer and immunologic diseases can only succeed if diverse investigators work and think together across preconceived boundaries. MAVRC endeavors to identify support to integrate the talents, both conceptual and technical, of University of Colorado scientists and clinicians who recognize, and strive to combat, the problems that affect our state, our country, and our world.
MAVRC Opportunities!
|
REQUEST FOR APPLICATIONS: MAVRC PILOT AWARDS IN HUMAN IMMUNOBIOLOGY
The Mucosal and Vaccine Research Colorado (MAVRC) program is soliciting applications for Pilot Award Funding of collaborative human immunobiology studies.
Eligibility
Applicant teams will include basic and clinical faculty investigators, with an emphasis on new interdepartmental or inter-institutional collaborations. Academic researchers are invited to become MAVRC members. Join MAVRC.
Proposals will represent new and creative projects investigating human immunobiology, supported by a concrete plan for specific subsequent external funding. Submissions will be reviewed by the MAVRC Board of Directors for significance, innovation, approach, and budget. Relevant IRB approval must be attained prior to award allocation.
- Two innovative pilot awards will be selected to receive a $20,000 award.
- Studies are to be conducted within a one-year period, with no carryover.
- Projects must begin within three months of receiving the award.
- The awards will cover Direct Costs only.
Applications and Award Notifications
- Three-page proposal in NIH PDF format.
- Application Due Date: October 1, 2010
- Submit Applications by e-mail to: MAVRC@ucdenver.edu
- Notification of Awards: November 15, 2010
Download: Complete Application Notification
___________________________________________________________________________________ |
|
NEW RFA IN MUCOSAL AND IMMUNE BIOLOGY
NIH Grant Title "Immune Defense Mechanisms at the Mucosa Cooprative Study Group"
MAVRC Members are welcome to pursue this opportunity on their own or if you are looking to develop ideas or onsite collaboration, we will be happy to set up meetings and provide administrative support for this application.
View the complete NIH Announcement: RFA-AI-10-008
Due Date: October 22, 2010
Funds Available: Budgets up to $250,000 Direct Costs per year and time periods up to five years may be requested.
NEW RFA IN MUCOSAL AND IMMUNE BIOLOGY
NIH Grant Title "Immune Defense Mechanisms at the Mucosa Cooprative Study Group"
MAVRC Members are welcome to pursue this opportunity on their own or if you are looking to develop ideas or onsite collaboration, we will be happy to set up meetings and provide administrative support for this application.
View the complete NIH Announcement: RFA-AI-10-008
Due Date: October 22, 2010
Funds Available: Budgets up to $250,000 Direct Costs per year and time periods up to five years may be requested.
___________________________________________________________________________________ |
|
INDIVIDUALIZED FUND SEARCH AVAILABLE
The Office of Research Development and Education (ORDE) is as faculty resource dedicated to bringing you valuable information and tools related to your efforts to obtain external funding for your projects. ORDE increases the University's competitiveness in terms of funding received from federal, state and private sources.
- Personalized Fund Search
- Potential funding agencies
- Contacting program officers
- Proposal development
- Funding sustainability
For more information contact: Carola Hagenau Email: Carola.Hagenau@ucdenver.edu
|
Learning Event
- Rocky Mountain Virology Club, Tenth Annual Meeting Keynote Speaker Bennie Osburn, DVM, PhD "The Progression of Bluetongue Viruses as an Ecological and Climatic Model of Vectorborne Disease." Pingree Park, CO September 24-25, 2010, Contact: Randall.Cohrs@ucdenver.edu to register.
- AMC Immunology Journal Club--All Welcome. Noon-1:00 PM. Mondays. Barbara Davis Center (BDC) 2nd Fl. Conf. Room #2104. Barbara Davis Center and Rheumatology Division. For additional information, contact: Taras.Lyubchenko@ucdenver.edu
- Immunological Mechanisms of Vaccination. Part of the Keystone Symposia Global Health Series, Supported by the Bill & Melinda Gates Foundation. October 27 - November 1, 2010. Sheraton Seattle Hotel, Seattle, WA. Registration Deadlines and Pricing
- University of Colorado School of Medicine, Tropical Medicine and Global Health Course. Content Includes: Community Health, Infectious Diseases, Nutrition, Maternal-child Health, Sanitation, Basic Epidemiology and More! November 1-12, 2010. UCDenver, Anschutz Medical Campus Space is limited, register by September 17, 2010.
These paylines apply to applications going to the May 2010 Council.
- New Investigator - 16%
- Seasoned Investigator - 11%
- R21 - 31 Overall Score